Login to Your Account



Other News To Note


Monday, December 12, 2011
• TaiGen Biotechnology Co. Ltd., of Taipei, Taiwan, said Warner Chilcott plc, of Ardee, Ireland, will transfer the worldwide rights for nemonoxacin, a nonfluorinated quinolone antibiotic in development for antibiotic-resistant infections, to TaiGen, giving the biotech worldwide rights to the drug.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription